[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:immune-effector-cell-associated-hemophagocytic-lymphohistiocytosis-like-syndrome":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07424222","Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)",[11],"Phase 1","RECRUITING","2026-08-03T01:01:37.762360Z","2026-07-19T19:36:05.141755Z",[],[]]